360 related articles for article (PubMed ID: 27188165)
1. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M
BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165
[TBL] [Abstract][Full Text] [Related]
2. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
3. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
5. [Ketamine as an NMDA receptor antagonist].
Kushikata T; Hirota K
Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892
[TBL] [Abstract][Full Text] [Related]
6. Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant.
Lavender E; Hirasawa-Fujita M; Domino EF
Behav Brain Res; 2020 Jul; 390():112631. PubMed ID: 32437885
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of GluA1 expression by ketamine and memantine.
Zhang K; Yamaki VN; Wei Z; Zheng Y; Cai X
Behav Brain Res; 2017 Jan; 316():152-159. PubMed ID: 27599619
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
9. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect.
Bottemanne H; Berkovitch L; Gauld C; Balcerac A; Schmidt L; Mouchabac S; Fossati P
Neurosci Biobehav Rev; 2023 Nov; 154():105410. PubMed ID: 37793581
[TBL] [Abstract][Full Text] [Related]
10. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
11. Instant and Lasting Down-Regulation of NR1 Expression in the Hippocampus is Associated Temporally with Antidepressant Activity After Acute Yueju.
Xia B; Zhang H; Xue W; Tao W; Chen C; Wu R; Ren L; Tang J; Wu H; Cai B; Doronc R; Chen G
Cell Mol Neurobiol; 2016 Oct; 36(7):1189-96. PubMed ID: 26825573
[TBL] [Abstract][Full Text] [Related]
12. How much alcohol is in ketamine's antidepressant action?
Bonnet U
Life Sci; 2017 Jan; 168():54-57. PubMed ID: 27836553
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.
Gideons ES; Kavalali ET; Monteggia LM
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8649-54. PubMed ID: 24912158
[TBL] [Abstract][Full Text] [Related]
14. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
[TBL] [Abstract][Full Text] [Related]
15. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
[TBL] [Abstract][Full Text] [Related]
16. N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
Lin JC; Chan MH; Lee MY; Chen YC; Chen HH
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():7-13. PubMed ID: 27296677
[TBL] [Abstract][Full Text] [Related]
17. Ketamine and phencyclidine: the good, the bad and the unexpected.
Lodge D; Mercier MS
Br J Pharmacol; 2015 Sep; 172(17):4254-76. PubMed ID: 26075331
[TBL] [Abstract][Full Text] [Related]
18. [Resolvins as novel targets for rapid-acting antidepressants].
Deyama S
Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
[TBL] [Abstract][Full Text] [Related]
19. Methoxetamine: from drug of abuse to rapid-acting antidepressant.
Coppola M; Mondola R
Med Hypotheses; 2012 Oct; 79(4):504-7. PubMed ID: 22819129
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine.
Tarrés-Gatius M; Miquel-Rio L; Campa L; Artigas F; Castañé A
Transl Psychiatry; 2020 Dec; 10(1):427. PubMed ID: 33303736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
